
JOHNSON & JOHNSON
JNJ · NYSE
Updated at 2026-10-14 10:14:06
- Today's High
- $256.18
- Today’s Low
- $245.17
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $261.60
- Previous Close
- $263.73
- Volume
- 5.9M
- Market Cap
- $635.56B
- P/E Ratio
- 30.07X
- EPS
- $8.62
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - GENERAL
- Headquarters
- ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK, NJ, UNITED STATES, 08933
- Country
- US
- Listing Date
- 1944-09-25
- Fiscal Year End
- December
- Shares Outstanding
- 2.4B
- CIK
- 0000200406
- Website
- www.jnj.com
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Financial Metrics
Revenue
2026-06-30
$25.31B
2026-03-31
$24.06B
2025-12-31
$24.56B
2025-09-30
$23.99B
Operating Expenses
2026-06-30
$10.08B
2026-03-31
$9.56B
2025-12-31
$11B
2025-09-30
$9.59B
Net Income
2026-06-30
$5.53B
2026-03-31
$5.23B
2025-12-31
$5.11B
2025-09-30
$5.15B
Net Profit Margin
2026-06-30
21.86%
2026-03-31
21.75%
2025-12-31
20.82%
2025-09-30
21.47%
Earnings Per Share
2026-06-30
$2.90
2026-03-31
$2.70
2025-12-31
$2.46
2025-09-30
$2.80
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$8.98B
2026-03-31
$8.26B
2025-12-31
$7.19B
2025-09-30
$9.28B
Effective Tax Rate
2026-06-30
17.97%
2026-03-31
12.6%
2025-12-31
-3.02%
2025-09-30
31.24%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $25.31B | $24.06B | $24.56B | $23.99B |
| Operating Expenses | $10.08B | $9.56B | $11B | $9.59B |
| Net Income | $5.53B | $5.23B | $5.11B | $5.15B |
| Net Profit Margin | 21.86% | 21.75% | 20.82% | 21.47% |
| Earnings Per Share | $2.90 | $2.70 | $2.46 | $2.80 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $8.98B | $8.26B | $7.19B | $9.28B |
| Effective Tax Rate | 17.97% | 12.6% | -3.02% | 31.24% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.